21
Tue, Jan
110 New Articles

Brandl Talos, Herbst Kinsky, and Schoenherr Advise on Graph Therapeutics' USD 3.1 Million Pre-Seed Financing Round

Austria
Tools
Typography
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

Brandl Talos has advised Graph Therapeutics on a USD 3.1 million pre-seed financing round led by Squareone and Merantix Capital, with participation from NAVEC Investment Management and angel investors, including the Atomico Angel Program. Herbst Kinsky advised NAVEC. Schoenherr advised Squareone. Fladgate reportedly advised the Atomico Angel Program.

Graph Therapeutics is a Vienna company focusing on AI-driven drug discovery for inflammatory and immunological diseases.

The Brandl Talos team included Partner Stephan Strass and Associate Lara Praethaler.

The Herbst Kinsky team included Partner Philipp Kinsky.

The Schoenherr team included Partner Thomas Kulnigg and Attorney at Law Clemens Pretscher.

Schoenherr at a Glance

Schoenherr is a leading full-service law firm providing local and international companies stellar advice that is straight to the point. With 15 offices and 4 country desks Schoenherr has a firm footprint in Central and Eastern Europe. Our lawyers are recognised leaders in their specialised areas and have a track record of getting deals done with a can-do, solution-oriented approach. Quality, flexibility, innovation and practical problem-solving in complex commercial mandates are at the core of our philosophy.

Firm's website: www.schoenherr.eu